Clinical Trials

The standard therapy for newly diagnosed metastatic non-small cell lung cancer is Keytruda by Merck. That is the standard that PD-1 latecomer GSK's Jemperli must meet, and the medication has succeeded in doing so. In a phase 2 trial, individuals...

Everyone eligible for both shots will often receive them at the same time during the COVID and flu vaccination campaigns in the fall. Interestingly, according to a top testing specialist, if you recently had a case of COVID, you...

In the United States, adults and kids with monkeypox infection are now being enrolled in a Phase 3 clinical trial assessing the antiviral tecovirimat, better known as TPOXX. The study's researchers hope to include more than 500 participants from...

Amgen is in the lead in a carefully watched race among KRAS inhibitors after winning a lung cancer randomised study. Now, the California drugmaker is giving an early peek at the precise data that might set the benchmark for...

The European Commission (EC), Heads of Medicine Agencies (HMA), and European Medicines Agency (EMA) have released the 2022–2026 workplan for the programme Accelerating Clinical Trials in the EU (ACT EU). Building on the Clinical Trials Regulation (CTR) and Clinical Trials...

After unimpressive evidence on tumour progression, many Gilead Sciences investors have stopped believing in Trodelvy in HR-positive, HER2-negative breast cancer. But now that the antibody-drug combination has unexpectedly returned, blockbuster dreams have been rekindled thanks to a life extension...

Bristol Myers Squibb and 2seventy bio, Inc.announced positive topline results from KarMMa-3, a Phase 3, global, randomized, multicenter, open-label study evaluating Abecma (idecabtagene vicleucel) compared to standard combination regimens in adults with multiple myeloma that is relapsed and refractory...